Steve Albers is Senior Vice President, Market Access and Public Affairs for Novo Nordisk Inc. since November 2020. Steve leads the US Market Access team in setting strategies and …

Novo Nordisk’s product portfolio includes several injectable medications (in both vial and pen device) that require the use of needles, as well as pen needles. More information about Novo …

Novo Nordisk also offers a free of charge home generated medical sharps containment and disposal system to CA and MN residents using our product portfolio. These services are also …

Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.

Learn about the Novo Nordisk Industry Practice PharmD Fellowship, a competitive postdoctoral opportunity for recent PharmD graduates. View information about the program here.

Novo Nordisk offers a free of charge home generated medical sharps containment and disposal system to CA residents using our product portfolio. Patients may visit …

Novo Nordisk is a member of the Pharmaceutical Product Stewardship Work Group (PPSWG). As part of PPSWG, Novo Nordisk supports PPSWG efforts to comply with local requirements …

In this role, you will be joining a newly established and growing area in our company, responsible for designing, planning, and building all major fill & finish expansion projects across Novo …

Nov 19, 2024 · Novo Nordisk expects to file for regulatory approvals in the US in the first half of 2025. About ESSENCE (semaglutide 2.4 mg) ESSENCE is a Phase 3 trial evaluating the …

At Novo Nordisk, we are the world leader in diabetes care and a major player in defeating other serious chronic conditions such as obesity, growth hormone-related disorders and rare …